Hubei Kailong Chemical Group Co., Ltd.

SZSE:002783.SZ

9.22 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q1
Revenue 952.154675.1011,064.8541,002.552927.045784.307916.808860.043942.121686.973744.772690.088774.474531.958779.338522.487536.579172.538524.888489.18517.98359.324553.619493.014507.734310.843367.055356.076404.114231.705283.856232.057275.736162.064236.808243.159248.512162.126246.594147.405
Cost of Revenue 709.509491.299808.829723.932625.961589.365724.342623.516708.328535.301596.158533.887567.273416.77664.063327.558342.051122.5323.981301.567325.932247.676349.827329.398331.96223.762230.122225.668247.509151.981163.088141.254152.44998.891128.752161.107161.751103.49100
Gross Profit 242.646183.802256.026278.62301.084194.941192.467236.527233.793151.673148.614156.201207.201115.188115.275194.929194.52850.038200.907187.614192.047111.648203.792163.615175.77487.081136.933130.408156.60579.724120.76890.803123.28763.173108.05682.05286.76158.635246.594147.405
Gross Profit Ratio 0.2550.2720.240.2780.3250.2490.210.2750.2480.2210.20.2260.2680.2170.1480.3730.3630.290.3830.3840.3710.3110.3680.3320.3460.280.3730.3660.3880.3440.4250.3910.4470.390.4560.3370.3490.36211
Reseach & Development Expenses 30.84312.90417.05423.39222.68117.58212.5727.54415.32111.5019.8511.98215.6528.0029.0588.3777.8384.70114.9811.78313.4910.60613.0648.59518.373012.95511.32517.11030.08016.552026.46909.086000
General & Administrative Expenses -45.68787.946-97.176227.964-41.73373.028-176.728208.802-44.86977.795-149.809188.466-32.24660.928-77.04151.512-23.27237.257-64.51845.033-14.61731.144-56.82440.469-18.52734.413-78.33245.694-15.20930.847-49.7720.56-14.35922.3731.53721.02313.37119.67600
Selling & Marketing Expenses 28.20621.32325.95323.84622.85921.68319.19422.6516.65218.78326.54917.73417.29815.209-67.63456.55450.53616.64369.63362.88147.71831.11664.96143.2442.70526.48143.79142.94943.96427.81449.98129.62739.24518.9238.42828.52821.28317.82800
SG&A 107.196109.269-71.223251.81-18.87594.711-157.533231.452-28.21796.578-123.259206.2-14.94776.137-144.675108.06727.26453.95.116107.91433.10162.268.13783.70924.17860.894-34.54188.64428.75658.6610.21150.18724.88741.2969.96549.55138.1637.50400
Other Expenses 0.782-44.879-28.610.94-0.3341.531248.345-121.468122.918-1.918-5.643-1.4930.1690.022-14.3851.051-0.733-2.2641.509-0.6020.4090.055-8.037-0.9720.0910.628-6.0760.9523.8761.7711.6880.8642.6932.9313.271.179-203.488-145.705-477.458-124.16
Operating Expenses 137.256116.42131.849146.603141.155113.823103.381137.528110.022106.161152.885113.907117.52887.28921.599118.19199.42757.987149.261123.35295.61273.782139.55294.6785.90663.44495.88592.39989.21960.90589.54352.01871.31643.17272.62152.001-203.488-145.705-477.458-124.16
Operating Income 105.38993.48961.62498.703125.40744.596-39.31684.88675.91922.559-577.59418.55468.146-2.65714.27655.90780.237-15.377-24.35547.66298.65729.6838.55755.34293.22218.61337.79538.16973.81624.02833.13739.15552.72318.141-299.93128.96145.02516.421-230.86423.245
Operating Income Ratio 0.1110.1380.0580.0980.1350.057-0.0430.0990.0810.033-0.7760.0270.088-0.0050.0180.1070.15-0.089-0.0460.0970.190.0830.0150.1120.1840.060.1030.1070.1830.1040.1170.1690.1910.112-1.2670.1190.1810.101-0.9360.158
Total Other Income Expenses Net -19.132-44.879-116.4670.94-0.3340.5082.305-25.4420.99266.984-5.643-25.233-21.358-30.534-93.784-19.78-15.597-9.692-74.492-17.2022.63-8.129-63.72-14.5763.445-4.396-7.9861.0069.396.6583.3841.1943.3821.054561.0280.075143.163-144.989516.942-122.64
Income Before Tax 86.25748.61133.01499.643125.07345.104-37.01159.44476.91189.543-583.23817.0668.314-2.635-0.10856.95879.504-17.641-22.84647.0699.06629.7370.5254.36993.31319.24133.06239.01576.77625.47734.6139.97955.35321.05438.6630.12646.97917.13737.26324.765
Income Before Tax Ratio 0.0910.0720.0310.0990.1350.058-0.040.0690.0820.13-0.7830.0250.088-0.005-00.1090.148-0.102-0.0440.0960.1910.0830.0010.110.1840.0620.090.110.190.110.1220.1720.2010.130.1630.1240.1890.1060.1510.168
Income Tax Expense 30.27411.71410.83918.34119.7856.924-5.6339.04511.18718.567-44.35810.96614.7044.624-2.41213.05112.2482.2614.78812.45913.7698.8873.81810.07215.9045.587.8368.22613.8816.1845.5847.21510.6384.0226.436.637151.251-139.374258.926-117.278
Net Income 38.30326.7845.65557.69782.64829.351-31.37838.18754.67765.744-439.371.76936.682-6.226-11.74531.84646.099-15.858-41.86718.64561.22611.972-18.92528.69761.75910.23318.90524.62352.8518.63624.31228.3240.13916.00828.79420.86236.93610.80627.15217.883
Net Income Ratio 0.040.040.0050.0580.0890.037-0.0340.0440.0580.096-0.590.0030.047-0.012-0.0150.0610.086-0.092-0.080.0380.1180.033-0.0340.0580.1220.0330.0520.0690.1310.080.0860.1220.1460.0990.1220.0860.1490.0670.110.121
EPS 0.0780.070.0150.150.220.077-0.0820.10.150.17-1.330.0060.12-0.02-0.0310.080.12-0.04-0.090.050.20.04-0.0590.090.190.050.0580.120.160.140.0730.210.120.0480.110.0830.150.0430.110.071
EPS Diluted 0.0780.070.0150.150.220.077-0.0820.0990.140.17-1.330.0060.12-0.02-0.030.080.12-0.04-0.090.050.20.04-0.0590.090.190.050.0580.120.160.140.0730.210.120.0480.110.0830.150.0430.110.071
EBITDA 191.47874.87494.57132.938161.93982.75979.618104.202118.47456.15-79.3648.40599.19834.89487.50193.3396.265-6.3359.58167.287106.53434.06656.59570.48497.73524.81168.3837.05890.58420.8244.10140.41660.80221.655-509.22230.51-91.926162.126-473.269147.405
EBITDA Ratio 0.2010.1110.0890.1330.1750.1060.0870.1210.1260.082-0.1070.070.1280.0660.1120.1790.179-0.0370.1140.1380.2060.0950.1020.1430.1920.080.1860.1040.2240.090.1550.1740.2210.134-2.150.125-0.371-1.9191